Laboratory Corporation of America Holdings
NYSE:LH

Watchlist Manager
Laboratory Corporation of America Holdings Logo
Laboratory Corporation of America Holdings
NYSE:LH
Watchlist
Price: 261.48 USD -1.61% Market Closed
Market Cap: 21.7B USD

Laboratory Corporation of America Holdings
Non-Reccuring Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Laboratory Corporation of America Holdings
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
Laboratory Corporation of America Holdings
NYSE:LH
Non-Reccuring Items
-$31.3m
CAGR 3-Years
N/A
CAGR 5-Years
43%
CAGR 10-Years
7%
Quest Diagnostics Inc
NYSE:DGX
Non-Reccuring Items
-$65m
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
N/A
CVS Health Corp
NYSE:CVS
Non-Reccuring Items
-$4.9B
CAGR 3-Years
21%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
Cigna Corp
NYSE:CI
Non-Reccuring Items
-$735m
CAGR 3-Years
N/A
CAGR 5-Years
-18%
CAGR 10-Years
-24%
Hims & Hers Health Inc
NYSE:HIMS
Non-Reccuring Items
-$6.1m
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Guardant Health Inc
NASDAQ:GH
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Laboratory Corporation of America Holdings
Glance View

Laboratory Corporation of America Holdings, commonly known as LabCorp, stands as a formidable player in the world of healthcare diagnostics. Emerging from a confluence of scientific innovation and business acumen, LabCorp has carved a niche within the intricate fabric of healthcare services. Since its inception, the company has excelled in offering a comprehensive suite of laboratory-based tests and services, empowering physicians and healthcare providers with critical insights needed for effective patient diagnosis and management. With its headquarters in Burlington, North Carolina, LabCorp operates a vast network of laboratories and patient service centers across the nation, providing services that range from routine blood work to sophisticated genomic testing. The essence of LabCorp’s business model lies in seamless integration across the healthcare continuum, driving both operational efficiency and profitability. Fundamentally, the company generates revenue by performing diagnostic tests on patient specimens, serving hospitals, managed care organizations, physician offices, and governmental agencies. As healthcare systems evolve towards precision medicine, LabCorp has harnessed emerging technologies and innovations like genomic testing to enhance its service offerings. This expansion not only aligns with changing healthcare paradigms but also fortifies its market leadership. By continually investing in research and development, LabCorp keeps its services at the cutting edge, ensuring steady growth and resilience in an ever-changing healthcare landscape.

LH Intrinsic Value
290.85 USD
Undervaluation 10%
Intrinsic Value
Price

See Also

What is Laboratory Corporation of America Holdings's Non-Reccuring Items?
Non-Reccuring Items
-31.3m USD

Based on the financial report for Sep 30, 2025, Laboratory Corporation of America Holdings's Non-Reccuring Items amounts to -31.3m USD.

What is Laboratory Corporation of America Holdings's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 10Y
7%

Over the last year, the Non-Reccuring Items growth was 92%.

Back to Top